Drug Database
Back to search

Belgium· BE-AMP-SAM483146-00

Donnafyta Premens 4 mg

A other gynecologicals product containing vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1, registered in Belgium by Will Pharma. The same ATC class is registered in 4 of our 19 countries.

ATC G02CX

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDonnafyta Premens 4 mgATCG02CXREGISTER NO.BE-AMP-SAM483146-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1 is registered in 4 of 19 countries.

Countries holding a registration under ATC G02CX (other gynecologicals), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1 products by name

Vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1 · ATC G02CX

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Vitex agnus-castus L., Fruit, Dry Extract, Ethanol, 60, 7-13_1
Manufacturer
Will Pharma
Country
Belgium (BE)
ATC code
G02CX
ATC class
Other gynecologicals
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    3392164
  • be_apb
    3392172

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under G02CX

Other gynecologicals, as other registers publish it.

All vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1 products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2a9be2c9-76ea-417b-89d7-4b67272ebe43
GET /v1/drugs/2a9be2c9-76ea-417b-89d7-4b67272ebe43?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Donnafyta Premens 4 mg",
  "name_fr": "Donnafyta Premens 4 mg",
  "name_nl": "Donnafyta Premens 4 mg",
  "amp_code": "SAM483146-00",
  "strengths": [
    "4.0000",
    "4.0000"
  ],
  "pack_count": 16,
  "substances": [
    "Vitex agnus-castus L., Fruit, Dry Extract, Ethanol, 60, 7-13_1"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Other Gynecologicals",
  "authorisation_numbers": [
    "BE-TU483146"
  ]
}
API referenceMCP serverPlans

See everything about vitex agnus-castus l., fruit, dry extract, ethanol, 60, 7-13_1.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console